The Health Technology Assessment Policy and Methods Review is a commitment in the 2022-2027 Strategic Agreement between the Commonwealth and Medicines Australia being conducted by the Department of Health.
The HTA Review is being undertaken by a Reference Committee. In this initial phase of the consultation, the Committee has sought feedback on specific questions, with responses to be made by electronic submission.
Research Australia has responded to two questions in the survey, highlighting the role that research in HTA can play in improving Australia’s system for HTA.
Research Australia’s submission is available here.
Research Australia looks forward to responding to the Reference Committee’s draft recommendations for change in the next phase of the Review.